BRIGHT MINDS BIOSCIENCES INC.（DRUG）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-08-17 | 6-K | FORM 6-K | SEC |
| 2026-06-03 | 6-K | FORM 6-K | SEC |
| 2026-06-02 | 6-K | FORM 6-K | SEC |
| 2026-05-28 | 6-K | — | SEC |
| 2026-05-20 | 6-K | FORM 6-K | SEC |
| 2026-02-13 | 6-K | FORM 6-K | SEC |
| 2026-01-09 | 6-K | FORM 6-K | SEC |
| 2026-01-09 | 6-K | FORM 6-K | SEC |
| 2026-01-08 | 6-K | — | SEC |
| 2026-01-07 | 6-K | FORM 6-K | SEC |
| 2026-01-07 | 6-K | — | SEC |
| 2026-01-06 | 6-K | — | SEC |
| 2026-01-05 | 6-K | — | SEC |
| 2025-11-17 | 6-K | FORM 6-K | SEC |
| 2025-11-07 | 6-K | FORM 6-K | SEC |
| 2025-11-07 | 6-K | FORM 6-K | SEC |
| 2025-09-05 | 6-K | — | SEC |
| 2025-08-15 | 6-K | FORM 6-K | SEC |
| 2025-08-11 | 6-K | FORM 6-K | SEC |
| 2025-05-28 | 6-K | — | SEC |
| 2025-05-21 | 6-K | — | SEC |
| 2025-05-14 | 6-K | — | SEC |
| 2025-04-29 | 6-K | — | SEC |
| 2025-03-05 | 6-K | — | SEC |
| 2025-02-24 | 6-K | — | SEC |
| 2025-02-14 | 6-K | FORM 6-K | SEC |
| 2025-01-08 | 6-K | — | SEC |
| 2024-11-21 | 6-K | FORM 6-K | SEC |
| 2024-11-05 | 6-K | FORM 6-K | SEC |
| 2024-10-21 | 6-K | — | SEC |
| 2024-10-18 | 6-K | — | SEC |
| 2024-10-16 | 6-K | FORM 6-K | SEC |
| 2024-10-16 | 6-K | — | SEC |
| 2024-10-03 | 6-K | FORM 6-K | SEC |
| 2024-09-12 | 6-K | — | SEC |
| 2024-08-15 | 6-K | FORM 6-K | SEC |
| 2024-05-17 | 6-K | FORM 6-K | SEC |
| 2024-05-17 | 6-K | FORM 6-K | SEC |
| 2024-02-13 | 6-K | FORM 6-K | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。